Profile
Mikael Asp is currently a Director at Qdoxx Pharma AB, Oasmia Animal Health AB, and Oasmia Incentive AB. He was previously the Chief Executive Officer at Vivesto AB from 2013 to 2016.
Asp is a graduate of the Royal Institute of Technology.
Mikael Asp active positions
| Companies | Position | Start |
|---|---|---|
Oasmia Animal Health AB | Director/Board Member | - |
Qdoxx Pharma AB | Director/Board Member | - |
Oasmia Incentive AB | Director/Board Member | - |
Former positions of Mikael Asp
| Companies | Position | End |
|---|---|---|
| VIVESTO AB | Chief Executive Officer | 01/06/2016 |
Training of Mikael Asp
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivesto AB
Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
Qdoxx Pharma AB | |
Oasmia Animal Health AB | |
Oasmia Incentive AB |
- Stock Market
- Insiders
- Mikael Asp
















